Based on 3 Analyst Ratings
444344.44% Upside
Date | Brokerage Firm | Analyst Name | Price Target | Price when Posted | Upside/Downside on Report Date | Details |
---|
A. Akari Therapeutics, Plc has been rated by research analysts at H.C. Wainwright in the past 90 days.